Last reviewed · How we verify
NCT06007469: PAT
Pedal Acceleration Time (PAT) as a Measure of Foot Perfusion
trial in Critical Limb Ischemia in 50 participants. Status unknown.
10 December 2023
Quick facts
| Lead sponsor | Liverpool University Hospitals NHS Foundation Trust |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 50 |
| Start date | 4 October 2023 |
| Primary completion | 10 December 2023 |
| Estimated completion | 3 December 2024 |
Conditions studied
- Critical Limb Ischemia — all drugs for Critical Limb Ischemia →
- Claudication, Intermittent — all drugs for Claudication, Intermittent →
Sponsor
Liverpool University Hospitals NHS Foundation Trust
Who can join
18 and older, any sex, with Critical Limb Ischemia or Claudication, Intermittent. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To identify a correlation between Toe Brachial pressure Index (TBPI) and Acceleration time of the pedal vessels. The aim would then to use this data to design a clinical study assessing the relationship between PAT and wound healing in patients with PAD.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06007469
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Critical Limb Ischemia
Currently open trials in the same condition.
- NCT04433572 — Temsirolimus Adventitial Delivery to Improve ANGioplasty and/or Atherectomy Revascularization Outcomes Below the Knee · Phase 3 · recruiting
- NCT06434194 — Serrantor OCT Study · NA · recruiting
- NCT06482892 — TP03HN106 in Patients With Critical Limb Ischemia · Phase 2 · recruiting
- NCT06296576 — Acceleration Time Assessment for Prediction of Critical Limb Ischemia · recruiting
- NCT06075940 — Evaluation of the MAGNITUDE® Bioresorbable Drug-Eluting Scaffold in the Treatment of Patients With Below the Knee Diseas · NA · recruiting
Other Liverpool University Hospitals NHS Foundation Trust trials
Trials by the same sponsor.
- NCT07391553 — Achilles Tendon Rupture Patient Outcomes at 12 Months · not yet recruiting
- NCT07034469 — Air Tamponade Versus Fluorinated Gas Tamponade for Rhegmatogenous Retinal Detachment · NA · not yet recruiting
- NCT06566638 — Safety, Tolerability and Performance of the NucleoCapture Extracorporeal Therapeutic Apheresis Device in the Reduction o · NA · not yet recruiting
- NCT06600620 — Intelligent Monitoring to Predict Atrial Fibrillation · suspended
- NCT06271031 — Process Mapping and Data Collection to Inform a Computer Simulation Model of Hospitalised Patients With Bloodstream Infe · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06007469 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Liverpool University Hospitals NHS Foundation Trust
- Last refreshed: 23 August 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06007469.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing